Vanderbilt investigators have defined a gene expression program that controls the timing of synaptic remodeling – a process that is critical to brain development, learning and memory.

A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.

Eighteen-year-old Rachel Barnett of Robertson County is one of the first patients to be enrolled in the Undiagnosed Diseases Network (UDN) at Vanderbilt University Medical Center — one of seven medical centers around the country participating in a clinical research initiative of the National Institutes of Health to identify rare disorders in patients.

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

Choosing a career is like grading a diamond; you must consider your shortcomings, desires and values as well as your strengths, a biopharmaceutical company executive advised graduate students recently during a recent career conference at Vanderbilt University.

Understanding the action of a certain enzyme will shed light on basement membrane function, and on disorders ranging from diabetic kidney disease to cancer.